Ad is loading...
FEPUX vs SIFZX
FEPUX vs SIFZX Comparison
Open Charts FEPUX vs SIFZX
American Funds Europacific Growth 529F3
Price$55.55
Change+$0.16 (+0.29%)
VolumeN/A
Net Assets124.35B
Saturna International Z
Price$21.56
Change+$0.19 (+0.89%)
VolumeN/A
Net Assets64.41M
FEPUX vs SIFZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
FEPUX has more cash in the bank: 124B vs. SIFZX (64.4M). FEPUX pays higher dividends than SIFZX: FEPUX (1.45) vs SIFZX (0.09). FEPUX was incepted earlier than SIFZX: FEPUX (4 years) vs SIFZX (8 years). SIFZX (0.77) is less costly to investors than FEPUX (0.52). FEPUX is a more actively managed with annual turnover of: 30.00 vs. SIFZX (19.00). FEPUX has a lower initial minimum investment than SIFZX: FEPUX (250) vs SIFZX (1000). FEPUX annual gain was more profitable for investors over the last year : -3.32 vs. SIFZX (-7.73).
| FEPUX | SIFZX | FEPUX / SIFZX | |
| Total Expense Ratio | 0.52 | 0.77 | 68% |
| Annual Report Gross Expense Ratio | 0.52 | 0.77 | 68% |
| Fund Existence | 4 years | 8 years | - |
| Gain YTD | 3.638 | -3.216 | -113% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000 | 25% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 124B | 64.4M | 192,547% |
| Annual Yield % from dividends | 1.45 | 0.09 | 1,561% |
| Returns for 1 year | -3.32 | -7.73 | 43% |
| Returns for 3 years | 1.74 | 5.48 | 32% |
| Returns for 5 years | N/A | 57.84 | - |
| Returns for 10 years | N/A | N/A | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RMFFX | 56.55 | 0.18 | +0.32% |
| American Funds American Mutual R5 | |||
| VCINX | 12.08 | N/A | N/A |
| VALIC Company I International Growth | |||
| NIQCX | 13.24 | N/A | N/A |
| Neuberger Berman International Eq C | |||
| OSMCX | 31.60 | N/A | N/A |
| Invesco International Small-Mid Com C | |||
| BRKCX | 14.18 | -0.02 | -0.14% |
| MFS Blended Research Em Mkts Eq C | |||